Ascendis Pharma As Stock In The News
| ASND Stock | USD 143.18 1.65 1.14% |
The overall news coverage of Ascendis Pharma AS from major news outlets shows solid bullish sentiment on 8 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Ascendis Pharma's news coverage and content from conventional and social sources shows investors' bearish mood towards Ascendis Pharma AS. The specific impact of Ascendis Pharma news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Ascendis Pharma's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Ascendis Pharma headlines in addition to utilizing other, more conventional financial analysis modules. Check out Ascendis Pharma Backtesting and Ascendis Pharma Hype Analysis.
Ascendis |
Ascendis Pharma Today Top News and Investor Outlook
Ascendis Pharma AS Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Ascendis and other traded companies coverage. We help investors stay connected with Ascendis headlines for the 25th of April to make an informed investment decision based on correlating the impacts of news items on Ascendis Stock performance. Please note that trading solely based on the Ascendis Pharma AS hype is not for everyone as timely availability and quick action are needed to avoid losses.Ascendis Pharma stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Ascendis earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Ascendis Pharma that are available to investors today. That information is available publicly through Ascendis media outlets and privately through word of mouth or via Ascendis internal channels. However, regardless of the origin, that massive amount of Ascendis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ascendis Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ascendis Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ascendis Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ascendis Pharma alpha.
Ascendis Largest EPS Surprises
Earnings surprises can significantly impact Ascendis Pharma's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2017-05-23 | 2017-03-31 | -0.75 | -0.83 | -0.08 | 10 | ||
2016-08-31 | 2016-06-30 | -0.69 | -0.6 | 0.09 | 13 | ||
2018-03-28 | 2017-12-31 | -0.8 | -0.92 | -0.12 | 15 | ||
2016-11-30 | 2016-09-30 | -0.68 | -0.8 | -0.12 | 17 | ||
2022-05-11 | 2022-03-31 | -2 | -2.21 | -0.21 | 10 | ||
2015-08-24 | 2015-06-30 | -0.49 | -0.7 | -0.21 | 42 |
Ascendis Pharma Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Ascendis Pharma AS Stock. Current markets are slightly bullish. About 53% of major world exchanges and indexes are currently up. See today's market update for more information.
24th of April 2024
Ascendis Pharmas YORVIPATH gains UK authorization at investing.com
16th of April 2024
Nacuity Pharmaceuticals Expands Board of Directors with Appointment ofDr. Emmett Cunningha... at finance.yahoo.com
12th of April 2024
Ascendis Pharmas Options Frenzy What You Need to Know at benzinga.com
3rd of April 2024
Heres How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years at benzinga.com
27th of March 2024
Ascendis Pharma Updates Share Capital Structure - TipRanks.com - TipRanks at news.google.com
22nd of March 2024
Ascendis Pharma AS Rose on Positive Trial Results at finance.yahoo.com
21st of March 2024
Ascendis Pharma and MoonLake Immunotherapeutics dropped from Wedbush list By Investing.com... at news.google.com
15th of March 2024
Ascendis Pharma AS Given Average Rating of Moderate Buy by Analysts - MarketBeat at news.google.com
8th of March 2024
VISEN Announces Acceptance of a Biologics License Application for Lonapegsomatropin in Chi... at finance.yahoo.com
6th of March 2024
Is AdaptHealth Stock Outpacing Its Medical Peers This Year at zacks.com
6th of February 2024
Why Earnings Season Could Be Great for Ascendis Pharma at finance.yahoo.com
Ascendis Pharma Investors Sentiment
The influence of Ascendis Pharma's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ascendis. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ascendis Pharma's public news can be used to forecast risks associated with an investment in Ascendis. The trend in average sentiment can be used to explain how an investor holding Ascendis can time the market purely based on public headlines and social activities around Ascendis Pharma AS. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ascendis Pharma's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ascendis Pharma's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ascendis Pharma's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ascendis Pharma.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ascendis Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ascendis Pharma's short interest history, or implied volatility extrapolated from Ascendis Pharma options trading.
Check out Ascendis Pharma Backtesting and Ascendis Pharma Hype Analysis. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Ascendis Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ascendis Pharma. If investors know Ascendis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ascendis Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.11) | Revenue Per Share 4.739 | Quarterly Revenue Growth 5.014 | Return On Assets (0.30) | Return On Equity (8.18) |
The market value of Ascendis Pharma AS is measured differently than its book value, which is the value of Ascendis that is recorded on the company's balance sheet. Investors also form their own opinion of Ascendis Pharma's value that differs from its market value or its book value, called intrinsic value, which is Ascendis Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ascendis Pharma's market value can be influenced by many factors that don't directly affect Ascendis Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ascendis Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ascendis Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ascendis Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.